COGT
Price
$5.99
Change
+$0.35 (+6.21%)
Updated
Jun 5 closing price
Capitalization
680.86M
67 days until earnings call
KOD
Price
$4.08
Change
+$0.17 (+4.34%)
Updated
Jun 6, 10:44 AM (EDT)
Capitalization
206.83M
73 days until earnings call
Interact to see
Advertisement

COGT vs KOD

Header iconCOGT vs KOD Comparison
Open Charts COGT vs KODBanner chart's image
Cogent Biosciences
Price$5.99
Change+$0.35 (+6.21%)
Volume$2.76M
Capitalization680.86M
Kodiak Sciences
Price$4.08
Change+$0.17 (+4.34%)
Volume$100
Capitalization206.83M
COGT vs KOD Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. KOD commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and KOD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (COGT: $5.98 vs. KOD: $3.92)
Brand notoriety: COGT and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 189% vs. KOD: 63%
Market capitalization -- COGT: $680.86M vs. KOD: $206.83M
COGT [@Biotechnology] is valued at $680.86M. KOD’s [@Biotechnology] market capitalization is $206.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileKOD’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • KOD’s FA Score: 1 green, 4 red.
According to our system of comparison, KOD is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while KOD’s TA Score has 6 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 3 bearish.
  • KOD’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, KOD is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +8.53% price change this week, while KOD (@Biotechnology) price change was +9.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

KOD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($681M) has a higher market cap than KOD($207M). COGT YTD gains are higher at: -23.333 vs. KOD (-60.603). KOD has higher annual earnings (EBITDA): -164.93M vs. COGT (-284.04M). COGT has more cash in the bank: 246M vs. KOD (198M). COGT has less debt than KOD: COGT (17.1M) vs KOD (73.4M). COGT (0) and KOD (0) have equivalent revenues.
COGTKODCOGT / KOD
Capitalization681M207M329%
EBITDA-284.04M-164.93M172%
Gain YTD-23.333-60.60339%
P/E RatioN/AN/A-
Revenue00-
Total Cash246M198M124%
Total Debt17.1M73.4M23%
FUNDAMENTALS RATINGS
COGT vs KOD: Fundamental Ratings
COGT
KOD
OUTLOOK RATING
1..100
1910
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for COGT (81) in the Miscellaneous industry. This means that KOD’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (71) in the Miscellaneous industry is in the same range as KOD (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to KOD’s over the last 12 months.

KOD's SMR Rating (95) in the Biotechnology industry is in the same range as COGT (96) in the Miscellaneous industry. This means that KOD’s stock grew similarly to COGT’s over the last 12 months.

KOD's Price Growth Rating (64) in the Biotechnology industry is in the same range as COGT (65) in the Miscellaneous industry. This means that KOD’s stock grew similarly to COGT’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that KOD’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTKOD
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMIFX10.75N/A
N/A
Transamerica Mid Cap Growth R4
EKJCX2.93N/A
N/A
Allspring Premier Large Co Gr C
GGLCX12.22N/A
N/A
Gabelli International Small Cap C
JDVIX15.83N/A
N/A
JHancock Disciplined Value Intl I
FIQDX8.59N/A
N/A
Fidelity Advisor Strategic Real Ret Z

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+6.03%
SPHDF - COGT
63%
Loosely correlated
N/A
XNCR - COGT
55%
Loosely correlated
+0.22%
IDYA - COGT
53%
Loosely correlated
-0.09%
RARE - COGT
53%
Loosely correlated
+0.76%
CRNX - COGT
52%
Loosely correlated
+0.59%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-1.26%
XNCR - KOD
53%
Loosely correlated
+0.22%
IMNM - KOD
47%
Loosely correlated
+1.16%
COGT - KOD
47%
Loosely correlated
+6.03%
BEAM - KOD
47%
Loosely correlated
-0.87%
IDYA - KOD
46%
Loosely correlated
-0.09%
More